 - Patient received cytotoxic agents for cytoreduction within three weeks or the interval in which a cycle of standard chemotherapy would be administered in a non-transplant setting prior to initiating the nonmyeloablative transplant conditioning; exceptions are hydroxyurea and imatinib mesylate 